chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Long lasting throbbing headache like non other, nose bleed, numbness on right arm, right shoulder, right cheek & face, muscle aches, fatigue, and tingling on forehead. Also felt dizzy.
Patient with 2 Pfizer vaccinations who admitted with positive COVID test.  Provider d/c note below:  "79 yo retired RN who has been battling metastatic cancer and recently became ill with Covid. She inadvertently took too much robitussin with codeine which caused her to pass out and fall. She improved as the meds metabolized out of her system. Daughters were able to do inventory of meds in the home. The meds found included various supplements and herbal otc sleep aids, including CBD gummies and a Nuleaf CBD drops.  Meds were reviewed with patient and daughters. Going forward they will be organizing a med box, pitching out old meds including sedating meds, and working with patient as she will allow. Daughters want to take her to travel for a few weeks before next chemo. Patient is not agreeable to that at this point"" we will consider it.""  Ok to continue appetite stimulant megestrol acetate as needed.    Regarding covid, minimally symptomatic at this point. Eupoxic. PT evaluated and deemed independent. "
Employee complains of pain right deltoid since vaccination- 10/28/2003. Complained of pain at rest and upon use of right arm. Has take Ibuprofen with relief, but pain returns when medication not taken.
9 days after vaccine patient developed varicella, (Fever 104) 1 gm for varicella (positive) on 9/12/17, IgG negative.
She was sore  at injection site later on day of injection (12/20) that developed into whole body muscle aches the next day (12/21). She also reported a cough started on 12/20 and this has persisted and slight Shortness of breath started 12/20 that has become worse today 12/21 where if she is moving around she needs to stop and take a few breaths.  She denied any feeling of life threatening shortness or breath or need to go to ER.  She has been instructed to contact employee health prior to coming back to work given cough/SOB not typically a reaction to vaccine.
Fatigue, myalgia, nausea, skin rash, rash began 7hrs postop remainder of sx began 24hrs post & lasted 48hrs;
Fever (1 day) abdominal cramps (1 day), extreme sweating (1 hr), ringing in ears (30 minutes), fatigue
Face was red and flushed throughout the entire day.  The next day when she woke up (approx 20 hours after vaccine) her upper lip was severely swollen 7/10 for severity.  noted itching and discomfort.  Given Benadryl liquid 10ml and ice - reduced swelling over 4 hours time. Second dose 4 hrs later for maintenance at 10ml.  No further dose required.  Follow up instructions given.
29Apr88 pt vax; 02Apr90 seen in clinic w/ bilateral mumps.
1. flu shot approx 11:30-12 noon (Thursday) 2. Had Egg Salad Sandwich for lunch-same day 3. 8-9 pm same day started with itchy back 4. Next day rash spread to front of trunk (upper chest) 5. Sat. rash covers back, front of trunk and arms, sees MD who presc. Methylprednisolone taper for 7 days and Benadryl 25 mg tab. 6 per 24 hrs. did so for 2 days.
This initial spontaneous case, was received from pharmacist on 20-Oct-2017, concerning a 23-year-old adult female patient. The patient had no relevant medical history and she did not receive any concomitant medications. On 20-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 179103, expiry date: May-2018). The patient under 65 years of age received the vaccine (explicitly coded as inappropriate age at vaccine administration). The reporter assessed the event as non-serious.
Mother states pt. had a fever off and on from Sunday 04/23/17 to Tuesday 4/25/17, and woke up with a mild rash on stomach, arms, legs, and face that resembles chickenpox. RN encouraged mother to call and follow-up with pt.'s PCP today 04/26/17, mother stated that she would.
Pt was 11 years old at time of vaccination. Her mother falsified her age information on the consent form.
Patient experienced dizziness, sweating, chills, muscle weakness about 10 minutes after administration. Patient described abdominal cramping as well after 20 minutes. Patient seemed out of it. Patient ws given water, cookies, and a drink. Patient requested to call paramedics. Paramedics arrived and took vitals. Patient seemed to get better. Paramedics gave the clear for patient to not go to hospital. Patient was able to leave on his own.
Patient said she had a headache for 7 days after the vaccine, and her face flushed very hot and red for 4 hours each evening.
This case was reported by medical assistant and described the occurrence of swollen leg in a 4-year-old male subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline) for prophylaxis. On 05 April 2006, the subject received 5th dose of Infanrix in the left thigh (lot AC14A008AA). On 05 April 2006, the subject also received inactivated poliomyelitis virus vaccine (IPOL, Aventis Pasteur) in the left thigh and measles, mumps and rubella virus vaccine (MMR II, Merck) in the left arm. On 06 April 2006, one day after vaccination with Infanrix, the subject experienced injection site swelling, injection site induration, injection site warmth, and an "8 by 7 cm. erythematous area" at the injection site and swelling, "from injection site to past the knee." The subject was seen at a physician's office and was treated with an unspecified antibiotic. The events resolved on an unspecified date on or after 06 April 2006 and on or before 04 May 2006. The nurse considered the events to possibly be related to vaccination with Infanrix.
Patient presented with Tachycardia on 12/04/2022 post Pfizer vaccination. Her caregiver stated her pulse was as high as 182 BPM.
Waited on site for 15 minutes per instructions. Reaction occurred offsite 25 minutes after injection. Sudden onset dizziness, nausea, tickle/scratchiness in throat followed by audible stridor. Had taken vistaril 50 mg at time of injection...added 50mg Benadryl, steroid and Pepcid. Medications resolved symptoms, did not go to ER. Notified my allergist and have appointment scheduled for 1/25 to discuss reaction and whether second dose is advisable.
Vaccine was given to a patient that was not eligible to receive vaccine (Moderna) as patient is 12 y/o. No adverse noted during assessment or reported after visit.
SkinRash Narrative: As reported by employee on 6/25/2021: ********************************************* "4 DAYS after 1st dose of Moderna I broke out in hairline and along the right side of my face in fluid filled raised achy bumps. When popped left black scarring." Any medications used for treatment? If so, what meds and doses: " Steroid Cream prescribed by PCP Dr."
Initial "numb" feeling in hand immediately after vaccination.  Then very quickly developed near-syncope: unable to stand or walk, very dizzy, felt like she would faint.  Symptoms lasted about 45 minutes before patient able to walk with assistance out of clinic.
administered to patient at inappropriate age.; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-year-old female patient who received DTPa (Infanrix) (batch number 4L9E4, expiry date 7th February 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 28th June 2021, the patient received Infanrix (intramuscular) .5 ml and Infanrix Pre-Filled Syringe Device. On 28th June 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The health care professional (Medical Assistant) reported that INFANRIX administered to a 11 years old patient which led to inappropriate age at vaccine administration. The Vaccine Administration Facility was the same as Primary reporter. The reporter consented to follow up. This case has been linked with US2021152836,US2021152845 and US2021152840 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021152845:same reporter US-GLAXOSMITHKLINE-US2021152840:same reporter US-GLAXOSMITHKLINE-US2021152836:same reporter
Was in good health until I had my vaccine. I developed unknown chest pains and went to the ER. I was showing no signs of being sick and when I was admitted to the ER I was having an irregular heart beat and my white count shot up to 17,000. I was diagnosed with pneumonia and sent home. Since then to date I have developed a twitch in my left leg and I have not been able to produce sweat since my injection.
Information has been received from a physician referring to a patient of unknown age and gender. Information about concurrent condition, medical history and concomitant therapy was not reported. The physician stated that many years ago the patient was vaccinated with a dose of VARIVAX (lot#, dose and route not reported). Many years later the patient had a red rash that resembled shingles. The physician stated that this was a previous event that happened 3 to 4 years ago. At the time of reporting, the outcome of red rash that resembled shingles was unknown. The physician did not provide the causality. Additional information has been requested.
On 08/09/23 Pt. was seen in our office for her routine four year old well exam and received Dtap-IPV IM on her right thigh, and MMRV SC on her left thigh. Per mother of patient, patient had reported that her right thigh felt very itchy after the immunization. On 08/10/23, mother of patient reported that patient woke up with a circular rash approximately the size of a quarter on her right thigh; location where the Dtap-IPV had been administered. Later that afternoon, the rash had increased in size and patient was brought to Urgent Care where the attending provider documented an erythematous rash on right upper thigh, warm to the touch and indurated measuring approximately 14 cm x 10 cm. Patient was prescribed Cephalexin oral antibiotics for 7 days and instructed to take Benadryl every 8hrs. Rash circumference was marked by attending and mother of patient was instructed to administer Cephalexin if rash increased the following day. On 08/11/23 pt was brought in by mother to be assessed by walk-in provider as rash had continued to spread on right thigh, covering right thing in it?s majority. Pt.'s mother reports to have administered the cephalexin antibiotic on 08/12/2023 and that the  rash began to improve at that time. As of 08/14/2023, I spoke with pt.'s mother who stated that the rash had now resolved after completion of the seven day course of antibiotics.
Patient did not have any symptoms.  This is just reporting inadvertently given the Bivalent when it should have been the Monovalent.
A small drop of vaccine dribbled out of patients arm post- vaccination. Since = or > the recommended dose was given, pt was not revaccinated per guidelines.
Pt was given 0.5 ml  (+3xs vaccine) of flu virus instead of 0.25 ml of flu virus. Pt had fever prior to vaccines. Pt continued to have fever reaching levels of 102.0 at 11:30 pm the night of vaccinations. Mom states pt is doing well and fever is down as of 4/13/12 mom denies any other symptoms occurring after vaccination.
Child became ill 2 days after vaccinations. He was diagnosed 12 days later with new onset Type 1 DM.
Pt tested positive on 11/21 in ED after having increased weakness, decreased appetite and energy level, and cough and headache for a few days. She was admitted on 11/23 with acute UTI, AKI superimposed on CKD stage III and fall at home.
severe body pain; ears ringing; faint feeling; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 00:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient previously received amoxicilline and morphine for unknown indication on an unknown date and experienced drug allergy. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Mar2021 at 14:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021 at 21:00 the patient experienced severe body pain, ears ringing and faint feeling. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events severe body pain, ears ringing and faint feeling were not resolved at the time of the report.   No follow up attempts are possible; information about lot/batch number cannot be obtained.
Redness and swelling to injection arm of right upper left arm. Patient went to urgent care and was given an antibiotic injection per patient. Patient presented to pharmacy with prescription for clindamycin 150 mg. Patient discharge papers diagnosed her with cellulitis/dermatitis.
not enough diluent was withdrawn to reconstitute the pfizer vaccine and as a result the patient received higher concentration of the vaccine than the normal dose
pt recv vax 28OCT97 & approx 4hr later pt became gray & limp;also had a brief high pitched cry;
No additional AEs; patient received improperly stored vaccine.; This spontaneous report was received from healthcare worker and refers to a 4-month-old patient of an unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 31-AUG-2022, the patient was vaccinated with improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid (lot #w004504, expiration date: 16-JUN-2023 or lot #w002562, expiration date: 12-OCT-2023) administered for prophylaxis (strength, and route of administration were not provided) (product storage error).  Administered dose of vaccine experienced the temperature excursion of 11.3 degrees Celsius for 34 minutes. There was no previous temperature excursion.  There was no adverse event reported (no adverse event).  This is one of two reports received from the same reporter (link report #2209USA001244).; Sender's Comments:  US-009507513-2209USA001244:
Initial report received from a healthcare professional on 24-Oct-2013. A patient whose age, gender, medical history and concomitant medications were not reported, received a dose of FLUZONE (lot number, route and site of administration was unknown) on an unknown date. On an unknown date, patient experienced adverse event. The outcome of the event was unknown. List of documents held by sender: none.
The night after receiving my Moderna Bivalent booster I felt a little sick. This was not unusual. I had received 3 previous Pfizer shots (2 in original series plus 1 booster), all of which resulted in some amount of fever and/or chills and/or fatigue that lasted a day or two but then dissipated completely. This Moderna shot did not have a particularly acute reaction in the first few days, but I was very fatigued. Unlike with the first 3 Pfizer shots, the fatigue persisted for several weeks and never totally lifted. I do suffer from chronic fatigue syndrome, but I have a baseline energy level that has remained rather consistent for a while -- it was markedly lower for the month following my Moderna booster. Then, on Oct 6, about a month after my Moderna booster, I developed a breakthrough covid infection. I would describe my symptoms as mild to moderate: low fever that went away, sore throat, mucus and congestion, fatigue (though not noticeably more tired than energy level since booster).
Initial report received from a consumer on 30 September 2014. A male patient with a history of multiple sclerosis received Influenza vaccine (manufacturer and lot number not reported) on an unspecified date and subsequently "got the flu". Previous multiple sclerosis treatment included GILENYA, AVONEX, BETASERON, and TYSABRI. The patient was taking AUBAGIO from 13 December 2012. It was not reported which, if any, of these treatments was ongoing at the time of influenza vaccination. Outcome was not reported. Documents held by sender: None.
Patient with lyme disease received the second shot of the vaccine and ended at hospital; A spontaneous report was received from a consumer, concerning a male patient of unspecified age and, who received Moderna's COVID-19 vaccine (mRNA-1273) and where patient with lyme disease received the second shot of the vaccine and ended at hospital.  The patient's medical history included lyme disease.  Concomitant medications use was not provided  On an unknown date, the patient received their second of two planned doses of mRNA-1273 (lot number: unknown) for prophylaxis of COVID-19 infection.    The reporter stated that her physician advised her not to have the second shot of vaccine as on an unspecified date, other patient with lyme disease had ended up at hospital after the second shot of vaccine, Treatment of this event was not provided.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of event, patient with lyme disease received the second shot of the vaccine and ended at hospital was considered unknown at the time of this report.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time as the reason for hospitalization is lacking.  Further information has been requested
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Oct2022 at 12:15 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 73 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 11Feb2021 at 12:15 as dose 1, single (Batch/Lot number: unknown), in left arm, on 04Mar2021 at 12:15 as dose 2, single (Batch/Lot number: unknown), in left arm, on 08Oct2021 at 12:15 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 06May2022 at 12:15 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Thalesemia Minor" (unspecified if ongoing). The patient had no known allergy. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19 including Paxlovid from 03Feb2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
Dizziness (disequilibrium, vertigo) for two weeks when bending over, looking up, turning head quickly, standing up quickly
After the shot my heart rate went way up to 148; after the shot heart rate was high and blood pressure went crazy; After the shot my heart rate went way up to 148; after the shot heart rate was high and blood pressure went crazy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Feb2021 (Lot number: EN6198) at the age of 65 years as dose 1, single and administered in arm left, administration date 17Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Restless legs syndrome" (unspecified if ongoing), notes: Verbatim: Restless leg syndrome; "Surgery" (unspecified if ongoing), notes: Verbatim: Surgery on right arm; "high blood pressure" (unspecified if ongoing), notes: I take pills for that and it's very much control without the problem. Concomitant medication(s) included: ROPINIROLE; LOSARTAN taken for blood pressure measurement; HYDROCHLOROTHIAZIDE. The following information was reported: HYPERTENSION (non-serious) with onset 2021, outcome "unknown", HEART RATE INCREASED (non-serious) with onset 2021, outcome "recovered" (2021) and all described as "After the shot my heart rate went way up to 148; after the shot heart rate was high and blood pressure went crazy". The event "after the shot my heart rate went way up to 148; after the shot heart rate was high and blood pressure went crazy" and "after the shot my heart rate went way up to 148; after the shot heart rate was high and blood pressure went crazy" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hypertension, heart rate increased.  Additional information: Patient had a reaction and happened to go to the Heart Doctor and everything after taking the Pfizer Covid-19 Vaccine. Consumer stated, It was the 3 days after the shot his heart rate went way up to 148 actually. He do have high blood pressure, take pills for that and it's very much control without the problem but after the shot heart rate was high and they gave me medicine for that and it lowered (Normal) his heart all over. Consumer stated, they put him on Metoprolol 25 mg twice a day and after that they put him on blood pressure medication that he was taking. Patient had no any prior vaccination. Consumer stated, After taking the vaccine his blood pressure went crazy. Consumer stated, he had blood test done before the shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Caregiver received first dose of Pfizer COVID-19 vaccine. After 10:00 minutes of observation phase, patient c/o lips tingling and "on fire". Lips not swollen, denies SOB, skin WNLs, denies difficulty swallowing. MERT called. Patient assessed, states tingling 8/10, no other symptoms. Patient given bottle of water and tolerating that fine. Allegra 60mg ordered and administered at 8:52am. Patient statedwas at a 2/10 10 minutes after getting the Allegra. Patient drinking water without difficulties. Patient remains without further symptoms, lips still 2/10 with tingling. Outpatient labwork ordered. Left at 1000 ambulatory to outpatient lab. Educated her to notify administrator of her symptoms prior to her second vaccine.
Bleeding immediately following flu shot. Visible bruising for 2 weeks. Firm area noted in right deltoid for 4.5 weeks. Soreness/pain in right arm/shoulder s/p shot and persisted for 5 weeks. Numbness & tingling developed 3.5 weeks after shot and persists in thumb as of now. Sought massage and chiro care to help with pain and numbness/tingling.
This is a place-holder VAERS.  County will also submit one.   Pt. is a re-vaccinee.  CDC Clinical Team was contacted by State Health Dept. because scab had not fallen off by 5/15/03.  Scab well-formed with few mm surrounding erythema.  No pain, tenderness, or drainage.  On 5/21/03, pt. noted scab had fallen off spontaneously.  Examined subsequently by Health Department physician who found vaccination site was well-healed and saw no need for swab.